Patient-derived liver and intestinal disease models are designed to help drug developers test whether a candidate reduces human disease in tissue before it reaches clinical trialsSAN DIEGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety and efficacy, today announced that it is extending its human tissue platform beyond toxicology, the core of its b ...

TORONTO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) announced today the appointment of Daan Dijkhuizen as its Chief AI Officer and a member of Constellation’s leadership team. Mr. Dijkhuizen is currently the Chief Executive Officer of the Topicus Operating Group within Topicus.com Inc., and Managing Partner of VMS Ventures, Constellation’s venture arm. Mr. Dijkhuizen will continue in both of those roles alongside his new position as Chief AI Of ...

PLAINVIEW, N.Y., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) plans to release its third quarter 2026 financial results after the market closes on Wednesday, November 4, 2026. The company will host a conference call to review these results starting at 5:00 PM ET that day. To join the call, dial (+1) 888-396-8049 (toll-free) or (+1) 416-764-8646. Participants may also access a live webcast of the call by visiting Veeco's investor relations website at ir.veeco.com. A replay of the w ...

AUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, today announced it will report its third quarter 2026 financial results before market open on Wednesday, November 4, 2026. A conference call for members of the investment community will be held at 8:30 a.m. E.T. that same day, during which the Company will discuss its third quarter 2026 results, its outlook and other business items. This call will ...

QXL's decoder leverages CUDA-Q QEC to manage to cutt logical errors by 12–13% on Google Quantum Hardware Data, in both standard and real-time streaming tests TEL AVIV, Israel, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (NASDAQ: QXL) (“Quantum X Labs”, “QXL” or the “Company”), a quantum technology company developing advanced solutions across quantum computing, quantum error correction, quantum software, cybersecurity and quantum sensing, today announced a key milestone: its quantum error-correctio ...

- Robin Swartz, Voyager’s Chief Business and Operating Officer, appointed President, effective immediately; expected to succeed Alfred W. Sandrock, Jr., M.D., Ph.D., as CEO in Q1 2027 - - Dr. Sandrock expected to remain CEO through initial acute safety data with VY1706, anticipated in Q1 2027 pending enrollment, and to subsequently continue as a member of Voyager’s Board of Directors - LEXINGTON, Mass., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedi ...

— STRO-006 is Sutro’s second wholly-owned ADC to enter the clinic in less than one year — — Initial clinical data expected in the second half of 2027 — SOUTH SAN FRANCISCO, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that the first patient has been dosed in its Phase 1 trial of STRO-006 in patients with a range of solid tumor ...

Shoppers’ browser-based AI agents can now find products and fill a cart on merchants’ own stores while the checkout remains on the storefrontAUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Commerce.com (Nasdaq: CMRC), the open commerce ecosystem built to help merchants win as AI reshapes how customers discover and buy, today announced a partnership with Cloudflare that lets AI agents in a customer’s web browser search, compare and shop directly on BigCommerce merchants’ online stores with no setup required ...

BOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 3, 2026 to report its third quarter 2026 financial results and provide a corporate update. Also today, Rhythm announced participation in two upcoming investor conferences: David M ...

Proposed collaboration covers scientific exchange, specialist training and real-world evidence, alongside assessment of clinical trial opportunities and a potential regional presence for NeOnc in Abu Dhabi Two children in Abu Dhabi are receiving investigational NEO100 through NeOnc’s Compassionate Care program, with a third expected this week CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 21, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a ...